US Stock MarketDetailed Quotes

Vivos Therapeutics (VVOS)

Watchlist

1.240
-0.070-5.34%

Close Apr 7 16:00 ET

1.220
-0.020-1.61%

Pre 07:05 ET

14.66MMarket Cap-0.70P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Vivos Therapeutics (VVOS) Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2025

(Q2)Jun 30, 2025

(Q1)Mar 31, 2025

(FY)Dec 31, 2024

(Q4)Dec 31, 2024

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

0.62%-4.16M

-14.63%-3.49M

-50.87%-3.8M

-6.24%-12.69M

-6.99%-2.94M

-49.54%-4.19M

-6.61%-3.05M

28.91%-2.52M

39.01%-11.95M

8.40%-2.75M

Net income from continuing operations

-106.30%-5.4M

-159.88%-5.01M

-2.68%-3.86M

18.02%-11.14M

33.62%-2.83M

-25.04%-2.62M

65.10%-1.93M

-120.96%-3.76M

43.04%-13.58M

30.05%-4.26M

Operating gains losses

----

101.02%31K

-97.70%5K

100.34%6K

-98.67%14K

100.24%6K

-487.07%-3.04M

-16.22%217K

Depreciation and amortization

163.01%384K

111.03%306K

21.23%177K

-6.44%581K

-3.36%144K

-2.01%146K

-2.03%145K

-16.57%146K

-7.17%621K

-11.83%149K

Other non cash items

--0

----

-87.36%11K

--0

----

--87K

----

Change In working capital

142.86%799K

155.87%871K

-153.12%-426K

-202.65%-2.94M

-135.21%-319K

-361.43%-1.86M

-254.05%-1.56M

244.21%802K

67.39%2.86M

-51.96%906K

-Change in receivables

-749.15%-501K

-85.50%19K

11.11%-288K

-189.41%-228K

-7.69%24K

-159.60%-59K

2,283.33%131K

-338.24%-324K

-65.82%255K

-93.64%26K

-Change in prepaid assets

246.15%114K

-78.57%-75K

63.45%237K

-106.80%-62K

-157.24%-87K

-125.49%-78K

-115.38%-42K

-19.89%145K

729.09%912K

-77.25%152K

-Change in payables and accrued expense

175.19%782K

201.61%822K

-170.16%-341K

-194.03%-1.09M

-72.29%276K

-597.61%-1.04M

-402.48%-809K

333.93%486K

356.89%1.16M

111.91%996K

-Change in other current liabilities

1,196.88%351K

489.09%214K

4,155.56%365K

-111.20%-129K

59.26%-33K

-129.63%-32K

-104.66%-55K

83.93%-9K

662.91%1.15M

30.77%-81K

-Change in other working capital

108.09%53K

86.10%-109K

-179.17%-399K

-134.70%-1.43M

-166.84%-499K

-7,177.78%-655K

-185.09%-784K

460.00%504K

-152.95%-611K

-141.01%-187K

Cash from discontinued investing activities

Operating cash flow

0.62%-4.16M

-14.63%-3.49M

-50.87%-3.8M

-6.24%-12.69M

-6.99%-2.94M

-49.54%-4.19M

-6.61%-3.05M

28.91%-2.52M

39.01%-11.95M

8.40%-2.75M

Investing cash flow

Cash flow from continuing investing activities

143.23%83K

-9,743.33%-5.91M

19.21%-122K

33.41%-568K

0.00%-165K

-24.68%-192K

75.51%-60K

47.75%-151K

7.68%-853K

17.50%-165K

Net PPE purchase and sale

143.23%83K

-1,185.00%-771K

19.21%-122K

29.27%-568K

0.00%-165K

-24.68%-192K

75.51%-60K

36.82%-151K

13.10%-803K

17.50%-165K

Net business purchase and sale

--0

----

--0

----

Net other investing changes

----

---50K

--0

Cash from discontinued investing activities

Investing cash flow

143.23%83K

-9,743.33%-5.91M

19.21%-122K

33.41%-568K

0.00%-165K

-24.68%-192K

75.51%-60K

47.75%-151K

7.68%-853K

17.50%-165K

Financing cash flow

Cash flow from continuing financing activities

-27.04%2.76M

54.86%11.46M

63.65%17.88M

-14.41%3.05M

3.79M

7.4M

-50.58%3.64M

10.92M

3.57M

Net issuance payments of debt

---531K

----

--0

----

Net common stock issuance

-43.48%2.43M

----

94.90%7.8M

-12.50%3.5M

--4.3M

----

--4M

Proceeds from stock option exercised by employees

--866K

-69.23%2.31M

--0

43.01%11.44M

--0

--7.5M

-50.74%3.94M

--8M

--0

Net other financing activities

--0

----

-26.37%-1.36M

-3.24%-446K

---509K

---100K

52.56%-306K

---1.08M

---432K

Cash from discontinued financing activities

Financing cash flow

-27.04%2.76M

54.86%11.46M

--0

63.65%17.88M

-14.41%3.05M

--3.79M

--7.4M

-50.58%3.64M

--10.92M

--3.57M

Net cash flow

Beginning cash position

-36.23%4.4M

-10.30%2.34M

281.01%6.26M

-53.31%1.64M

538.77%6.31M

75.11%6.9M

-62.94%2.61M

-53.31%1.64M

-85.36%3.52M

-85.30%988K

Current changes in cash

-122.13%-1.32M

-52.00%2.06M

-504.75%-3.92M

346.11%4.62M

-107.79%-51K

79.96%-592K

238.27%4.29M

-72.55%968K

90.85%-1.88M

120.47%655K

End cash Position

-51.09%3.09M

-36.23%4.4M

-10.30%2.34M

281.01%6.26M

538.77%6.31M

75.11%6.9M

-62.94%2.61M

-53.31%1.64M

Free cash flow

6.87%-4.08M

-37.23%-4.27M

-46.91%-3.92M

-4.00%-13.26M

-6.59%-3.11M

-48.24%-4.38M

-0.13%-3.11M

29.41%-2.67M

37.84%-12.75M

8.97%-2.91M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

Unqualified Opinion

	(Q3)Sep 30, 2025	(Q2)Jun 30, 2025	(Q1)Mar 31, 2025	(FY)Dec 31, 2024	(Q4)Dec 31, 2024	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	0.62%-4.16M	-14.63%-3.49M	-50.87%-3.8M	-6.24%-12.69M	-6.99%-2.94M	-49.54%-4.19M	-6.61%-3.05M	28.91%-2.52M	39.01%-11.95M	8.40%-2.75M
Net income from continuing operations	-106.30%-5.4M	-159.88%-5.01M	-2.68%-3.86M	18.02%-11.14M	33.62%-2.83M	-25.04%-2.62M	65.10%-1.93M	-120.96%-3.76M	43.04%-13.58M	30.05%-4.26M
Operating gains losses	----	----	----	101.02%31K	-97.70%5K	100.34%6K	-98.67%14K	100.24%6K	-487.07%-3.04M	-16.22%217K
Depreciation and amortization	163.01%384K	111.03%306K	21.23%177K	-6.44%581K	-3.36%144K	-2.01%146K	-2.03%145K	-16.57%146K	-7.17%621K	-11.83%149K
Other non cash items	--0	----	----	-87.36%11K	--0	--0	----	----	--87K	----
Change In working capital	142.86%799K	155.87%871K	-153.12%-426K	-202.65%-2.94M	-135.21%-319K	-361.43%-1.86M	-254.05%-1.56M	244.21%802K	67.39%2.86M	-51.96%906K
-Change in receivables	-749.15%-501K	-85.50%19K	11.11%-288K	-189.41%-228K	-7.69%24K	-159.60%-59K	2,283.33%131K	-338.24%-324K	-65.82%255K	-93.64%26K
-Change in prepaid assets	246.15%114K	-78.57%-75K	63.45%237K	-106.80%-62K	-157.24%-87K	-125.49%-78K	-115.38%-42K	-19.89%145K	729.09%912K	-77.25%152K
-Change in payables and accrued expense	175.19%782K	201.61%822K	-170.16%-341K	-194.03%-1.09M	-72.29%276K	-597.61%-1.04M	-402.48%-809K	333.93%486K	356.89%1.16M	111.91%996K
-Change in other current liabilities	1,196.88%351K	489.09%214K	4,155.56%365K	-111.20%-129K	59.26%-33K	-129.63%-32K	-104.66%-55K	83.93%-9K	662.91%1.15M	30.77%-81K
-Change in other working capital	108.09%53K	86.10%-109K	-179.17%-399K	-134.70%-1.43M	-166.84%-499K	-7,177.78%-655K	-185.09%-784K	460.00%504K	-152.95%-611K	-141.01%-187K
Cash from discontinued investing activities
Operating cash flow	0.62%-4.16M	-14.63%-3.49M	-50.87%-3.8M	-6.24%-12.69M	-6.99%-2.94M	-49.54%-4.19M	-6.61%-3.05M	28.91%-2.52M	39.01%-11.95M	8.40%-2.75M
Investing cash flow
Cash flow from continuing investing activities	143.23%83K	-9,743.33%-5.91M	19.21%-122K	33.41%-568K	0.00%-165K	-24.68%-192K	75.51%-60K	47.75%-151K	7.68%-853K	17.50%-165K
Net PPE purchase and sale	143.23%83K	-1,185.00%-771K	19.21%-122K	29.27%-568K	0.00%-165K	-24.68%-192K	75.51%-60K	36.82%-151K	13.10%-803K	17.50%-165K
Net business purchase and sale	--0	----	----	----	----	--0	----	----	----	----
Net other investing changes	----	----	----	----	----	----	----	----	---50K	--0
Cash from discontinued investing activities
Investing cash flow	143.23%83K	-9,743.33%-5.91M	19.21%-122K	33.41%-568K	0.00%-165K	-24.68%-192K	75.51%-60K	47.75%-151K	7.68%-853K	17.50%-165K
Financing cash flow
Cash flow from continuing financing activities	-27.04%2.76M	54.86%11.46M	0	63.65%17.88M	-14.41%3.05M	3.79M	7.4M	-50.58%3.64M	10.92M	3.57M
Net issuance payments of debt	---531K	----	----	----	----	--0	----	----	----	----
Net common stock issuance	-43.48%2.43M	----	----	94.90%7.8M	-12.50%3.5M	--4.3M	----	----	--4M	--4M
Proceeds from stock option exercised by employees	--866K	-69.23%2.31M	--0	43.01%11.44M	--0	--0	--7.5M	-50.74%3.94M	--8M	--0
Net other financing activities	--0	----	----	-26.37%-1.36M	-3.24%-446K	---509K	---100K	52.56%-306K	---1.08M	---432K
Cash from discontinued financing activities
Financing cash flow	-27.04%2.76M	54.86%11.46M	--0	63.65%17.88M	-14.41%3.05M	--3.79M	--7.4M	-50.58%3.64M	--10.92M	--3.57M
Net cash flow
Beginning cash position	-36.23%4.4M	-10.30%2.34M	281.01%6.26M	-53.31%1.64M	538.77%6.31M	75.11%6.9M	-62.94%2.61M	-53.31%1.64M	-85.36%3.52M	-85.30%988K
Current changes in cash	-122.13%-1.32M	-52.00%2.06M	-504.75%-3.92M	346.11%4.62M	-107.79%-51K	79.96%-592K	238.27%4.29M	-72.55%968K	90.85%-1.88M	120.47%655K
End cash Position	-51.09%3.09M	-36.23%4.4M	-10.30%2.34M	281.01%6.26M	281.01%6.26M	538.77%6.31M	75.11%6.9M	-62.94%2.61M	-53.31%1.64M	-53.31%1.64M
Free cash flow	6.87%-4.08M	-37.23%-4.27M	-46.91%-3.92M	-4.00%-13.26M	-6.59%-3.11M	-48.24%-4.38M	-0.13%-3.11M	29.41%-2.67M	37.84%-12.75M	8.97%-2.91M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion	--

No. Symbol 5D % Chg

United Microelectronics

UMC

+8.13%

Middle East conflict spreads to the stock market! How should investors respond?

A major turning point has emerged in the US-Iran situation! Trump announced a two-week suspension of military action against Iran, and both Show More

牛牛課堂

Mar 4 17:09

Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.

牛牛課堂

Mar 18 18:18

Hormuz, Term Structure and USO: Navigating the Energy Storm